IBM (NYSE: IBM) Watson Health and Pfizer Inc. (NYSE: PFE) have announced a collaboration that will utilize IBM Watson for Drug Discovery to help accelerate Pfizer's research in immuno-oncology, an approach to cancer treatment that uses the body's immune system to help fight cancer.

Nuritas, the Irish digital-biotechnology and R&D company founded by Dr Nora Khaldi, has announced it will triple its workforce in Ireland to over 60 in 2017 as part of a major expansion of its Irish operations. It has also confirmed U2 band members Bono and The Edge as investors in the company.

The Wyss Center, a not-for-profit neurotechnology organization based in Geneva, Switzerland, has launched a global neurotech innovation challenge to connect the human brain with the digital world. The Challenge seeks the most disruptive new technologies for brain stimulation and neural signal recording. The goal is to develop technology with a clinical application that could help paralyzed people move, overcome depression or memory loss, restore vision or address other nervous system disorders.

Agfa HealthCare announces today that it has signed an agreement to implement Enterprise Imaging for Radiology in the new Acibadem International Medical Center, expected to open in Amsterdam shortly. This is the first contract for Agfa HealthCare with a subsidiary of the largest supplier of healthcare services globally, Integrated HealthCare Holdings.

Opinion Article by John Morley, CEO, Formic.
Many of the most successful organisations in the world aim to deliver high quality services that are built around the needs of the customer, informed by the voice of frontline staff. So why not so for health?

Royal Philips (NYSE: PHG, AEX: PHIA) has announced the introduction of IntelliSpace Portal 9.0, the latest edition of its comprehensive, advanced visual analysis and quantification platform. Featuring a suite of multi-modality functions and expanded neurological tools, IntelliSpace Portal 9.0 helps radiologists detect, diagnose and follow-up on treatment of diseases, while using new machine learning capabilities to support the physician.

As communicated previously, Agfa-Gevaert NV ("Agfa") was approached by CompuGroup Medical SE ("CompuGroup"), who had indicated an interest in a potential acquisition of all of the issued shares of Agfa by way of a voluntary conditional public takeover offer.